Metropolitan Life Insurance Company (MetLife)’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,657
| Closed | -$60.2K | – | 1885 |
|
|
2024
Q1 | $60.2K | Hold |
1,657
| – | – | ﹤0.01% | 1316 |
|
|
2023
Q4 | $33.6K | Hold |
1,657
| – | – | ﹤0.01% | 1645 |
|
|
2023
Q3 | $29.4K | Buy |
1,657
+418
| +34% | +$7.43K | ﹤0.01% | 1690 |
|
|
2023
Q2 | $22.4K | Hold |
1,239
| – | – | ﹤0.01% | 1874 |
|
|
2023
Q1 | $15.6K | Hold |
1,239
| – | – | ﹤0.01% | 1999 |
|
|
2022
Q4 | $18.2K | Hold |
1,239
| – | – | ﹤0.01% | 2067 |
|
|
2022
Q3 | $21.2K | Hold |
1,239
| – | – | ﹤0.01% | 2000 |
|
|
2022
Q2 | $18.1K | Buy |
+1,239
| New | +$18.1K | ﹤0.01% | 2089 |
|
|
2021
Q1 | – | Sell |
-2,271
| Closed | -$93.9K | – | 2599 |
|
|
2020
Q4 | $93.9K | Buy |
+2,271
| New | +$93.9K | ﹤0.01% | 2385 |
|